Close Menu

IGC

NEW YORK (GenomeWeb News) – The University of Michigan and the International Genomics Consortium have partnered to create a nonprofit company to provide genomics services and analysis support for physicians in the clinic and for researchers in clinical trials.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare, the University of Arizona Cancer Center and the International Genomics Consortium will serve as a critical network Tissue Source Site for the Cancer Genome Atlas Program.

Led by the Critical Path Institute and Roche's Ventana Medical Systems, the project aims to fill a gap in the current biomarker pipeline, and will hopefully speed the progression of proposed biomarkers through the FDA's qualification pipeline, said a C-Path official.

The International Genomics Consortium and the Research Institute at Nationwide Children's Hospital will serve as Biospecimen Core Resources for The Cancer Genome Atlas.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.